Although multidrug transporter proteins induce chemo-resistance by enhancing the efflux of anticancer drugs from cancer cells, the therapeutic targeting of ABC transporters has been unsuccessful4,5 due to low binding affinity or low specificity of the inhibitors. The gene discussed is ABCG2; the disease is cancer.